✦ LIBER ✦

Role of receptor activator of nuclear factor-κB ligand and osteoprotegerin in bone cell biology

✍ Scribed by Lorenz C. Hofbauer; Armin E. Heufelder

Publisher: Springer
Year: 2001
Tongue: English
Weight: 119 KB
Volume: 79
Category: Article
ISSN: 0946-2716
DOI: 10.1007/s001090100226

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum osteoprotegerin and receptor activ

Serum osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) concentrations in allogeneic stem cell transplant-recipients: a role in bone loss?

✍ K. Kananen; L. Volin; K. Laitinen; T. Ruutu; M. J. Välimäki 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 136 KB

Expression of receptor activator of nucl

Expression of receptor activator of nuclear factor -κB ligand, receptor activator of nuclear factor -κB, and osteoprotegerin, following low-level laser treatment on deproteinized bovine bone graft in rats

✍ Yong-Deok Kim; Won-Wook Song; Seong-Sik Kim; Gyu-Cheon Kim; Dae-Seok Hwang; Sang 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 574 KB

Plasma levels of receptor activator of n

Plasma levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in patients with neuroblastoma

✍ Donatella Granchi; Alberto Garaventa; Ilaria Amato; Paolo Paolucci; Nicola Baldi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB

## Abstract Earlier reports showed that the balance between receptor activator of nuclear factor‐κB ligand (RANKL) and its decoy‐receptor osteoprotegerin (OPG) plays an important role in the pathogenesis of metastatic osteolysis induced by neuroblastoma cells. In this study, we investigated whether

The role of osteoprotegerin and receptor

The role of osteoprotegerin and receptor activator of nuclear factor κB ligand in the pathogenesis and treatment of rheumatoid arthritis

✍ Lorenz C. Hofbauer; Armin E. Heufelder 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB 👁 1 views

Significance of serum osteoprotegerin an

Significance of serum osteoprotegerin and receptor activator of nuclear factor κB ligand in Japanese prostate cancer patients with bone metastasis

✍ Naoto Kamiya; Hiroyoshi Suzuki; Takumi Endo; Makoto Takano; Masashi Yano; Makito 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 197 KB

Receptor activator of nuclear factor-κB

Receptor activator of nuclear factor-κB ligand and osteoprotegerin : Potential implications for the pathogenesis and treatment of malignant bone diseases

✍ Lorenz C. Hofbauer; Andreas Neubauer; Armin E. Heufelder 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 1 views

## Background: The current review summarizes the roles of the ligand, receptor activator of nuclear factor-kappab ligand (rankl), its receptor, receptor activator of nuclear factor-kappab (rank), and its decoy receptor, osteoprotegerin (opg), on osteoclast biology and bone resorption. furthermore,